Pyloric injection of botulinum toxin for the treatment of refractory GERD accompanied with gastroparesis: A preliminary report

Digestive Diseases and Sciences

Volumn 53, Issue 10, 2008, Pages 2621-2626

  Mirbagheri, Seyed Amir ^a   Sadeghi, Amir ^b   Amouie, Mahasti ^c   Mansouri, Siavash ^d   Forootan, Mojgan ^e   Rashidi, Armin ^b   Abouzari, Mehdi ^a,f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Oil Company Hospital   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f NONE   (Iran)

Author keywords

Botulinum toxin injection; Gastroesophageal reflux disease; Gastroparesis

Indexed keywords

BOTULINUM TOXIN; PROKINETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; MALE; PH MEASUREMENT; PRIORITY JOURNAL; REFRACTORY PERIOD; SCINTIGRAPHY; STOMACH EMPTYING; STOMACH PARESIS; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BOTULINUM TOXIN TYPE A; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROPARESIS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PYLORUS; TREATMENT OUTCOME;

EID: 50949115067     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0187-5     Document Type: Article

References (23)

1. MF Vaezi 2004 Refractory GERD: acid, nonacid, or not GERD? Am J Gastroenterol 99 989 990
2. KM Cunningham M Horowitz PS Riddell GJ Maddern JC Myers RH Holloway JM Wishart GG Jamieson 1991 Relations among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease Gut 32 1436 1440
3. RW McCallum DM Berkowitz E Lerner 1981 Gastric emptying in patients with gastroesophageal reflux Gastroenterology 80 285 291
4. M Horowitz RJ Fraser 1995 Gastroparesis: diagnosis and management Scand J Gastroenterol (Suppl) 213 7 16
5. I Soykan B Sivri I Sarosiek B Kiernan RW McCallum 1998 Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis Dig Dis Sci 43 2398 2404
6. JP Waring TH Baron WK Hirota JL Goldstein BC Jacobson JA Leighton JS Mallery DO Faigel 2003 American Society for Gastrointestinal Endoscopy, Standards of Practice Committee. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy Gastrointest Endosc 58 317 322
7. D Armstrong JR Bennett AL Blum J Dent FT De Dombal JP Galmiche L Lundell M Margulies JE Richter SJ Spechler GN Tytgat L Wallin 1996 The endoscopic assessment of esophagitis: a progress report on observer agreement Gastroenterology 111 85 92
8. M Camilleri WL Hasler HP Parkman EM Quigley E Soffer 1998 Measurement of gastrointestinal motility in the GI laboratory Gastroenterology 115 747 762
9. HA Ziessman FH Fahey FB Atkins J Tall 2004 Standardization and quantification of radionuclide solid gastric-emptying studies J Nucl Med 45 760 764
10. JP Guo AH Maurer RS Fisher HP Parkman 2001 Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis Dig Dis Sci 46 24 29
11. R Cuomo G Koek D Sifrim J Janssens J Tack 2000 Analysis of ambulatory duodenogastroesophageal reflux monitoring Dig Dis Sci 45 2463 2469
12. LF Johnson TR Demeester 1974 Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux Am J Gastroenterol 62 325 332
13. MQ Bromer F Friedenberg LS Miller RS Fisher K Swartz HP Parkman 2005 Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis Gastrointest Endosc 61 833 839
14. D Ezzeddine R Jit N Katz N Gopalswamy MS Bhutani 2002 Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis Gastrointest Endosc 55 920 923
15. BE Lacy EN Zayat MD Crowell MM Schuster 2002 Botulinum toxin for the treatment of gastroparesis: a preliminary report Am J Gastroenterol 97 1548 1552
16. P Gupta SS Rao 2002 Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report Gastrointest Endosc 56 770 772
17. DA Revicki AM Rentz D Dubois P Kahrilas V Stanghellini NJ Talley J Tack 2003 Development and validation of a patient-assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index Aliment Pharmacol Ther 18 141 150
18. DA Revicki AM Rentz D Dubois P Kahrilas V Stanghellini NJ Talley J Tack 2004 Gastroparesis cardinal symptom index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms Qual Life Res 13 833 844
19. V Velanovich SR Vallance JR Gusz FV Tapia MA Harkabus 1996 Quality of life scale for gastroesophageal reflux disease J Am Coll Surg 183 217 224
20. V Velanovich R Karmy-Jones 1998 Measuring gastroesophageal reflux disease: relationship between the health-related quality of life score and physiologic parameters Am Surg 64 649 653
21. Z Lin J Forster I Sarosiek RW McCallum 2004 Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation Diabetes Care 27 1071 1076
22. M Nouraie AR Radmard H Zaer-Rezaii H Razjouyan S Nasseri-Moghaddam R Malekzadeh 2007 Hygiene could affect GERD prevalence independently: a population-based study in Tehran Am J Gastroenterol 102 1353 1360
23. PG Jackson MA Gleiber R Askari SR Evans 2001 Predictors of outcome in 100 consecutive laparoscopic antireflux procedures Am J Surg 181 231 235